The results of our pilot study are encouraging, but due to the number of patients enrolled, the effect of iloprost on early graft function did not reach statistical significance.
← all excerpts
The PRAISE study: a prospective, multi-center, randomized, double blinded, placebo-controlled study for the evaluation of iloprost in the early postoperative period after liver transplantation (ISRCTN12622749).
1
—
—